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Abstract
Photoacoustic tomography (PAT) can create multiscale multi-contrast images of living biological
structures ranging from organelles to organs. This emerging technology overcomes the high
degree of scattering of optical photons in biological tissue by using the photoacoustic effect. Light
absorption by molecules creates a thermally induced pressure jump that launches ultrasonic waves,
which are received with acoustic detectors to form images. Different implementations of PAT
allow the spatial resolution to be scaled with the desired imaging depth in tissue while a high
depth-to-resolution ratio is maintained. As a rule of thumb, the achievable spatial resolution is on
the order of 1/200 of the desired imaging depth, which can reach up to 7 cm. PAT provides
anatomical, functional, metabolic, molecular, and genetic contrasts of vasculature, hemodynamics,
oxygen metabolism, biomarkers, and gene expression. We review the state of the art of PAT for
both biological and clinical studies and then outline the future.
Optical imaging of tissue offers potential advantages in distinguishing different structures
according to their chemical composition. As tissue is a highly scattering medium for
electromagnetic waves in the optical spectral range, methods that attempt to form images
from light passing through tissue fall into two categories—ballistic (minimally scattered)
optical microscopy and diffuse (multi-scattered) optical tomography. The former provides
fine resolution but with a low imaging depth in tissue—up to ~1 mm, as defined by the
optical diffusion limit (1, 2). When incident photons reach this limit, most of them have
undergone tens of scattering events, which scramble the photon paths and inhibit effective
optical focusing. In contrast, diffuse optical tomography can probe centimeters into tissue
but with poor spatial resolution—equal to ~1/3 of the imaging depth (3). Randomized paths
of the diffuse photons render the image reconstruction mathematically ill-posed. It remains a
challenge for pure optical imaging to attain fine spatial resolution at depths beyond the
optical diffusion limit.
Fortunately, photons in tissue can be converted into ultrasonic waves, which are scattered
much less. Absorption of photons by biomolecules thermoelastically induces pressure waves
through the photoacoustic effect. Photoacoustic tomography (PAT) forms images by
detecting the induced pressure waves. The conversion from optical to ultrasonic energy
immediately brings several advantages. First and foremost, capitalizing on the low acoustic
scattering of tissue—approximately 1,000 times less than optical scattering, PAT breaks
through the optical diffusion limit (4). Second, PAT enables multiscale high-resolution
imaging of biological structures ranging in size from organelles to organs using the same
contrast. Third, exciting different molecules at different optical wavelengths, PAT reveals
rich optical contrasts based on the chemical composition. Fourth, PAT images optical
absorption with 100% sensitivity (5), two orders of magnitude greater than those of confocal
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microscopy and optical coherence tomography (6). Fifth, PAT provides inherently
background-free detection because the photoacoustic amplitude is proportional to the optical
absorption; non-absorbing tissue components present no background. Sixth, unlike
fluorescence imaging, PAT ensures no leakage of excitation photons into detectors. Seventh,
unlike optical coherence tomography and ultrasonography, PAT is speckle-free (7). Last, all
molecules are optically absorbing at some wavelengths and can potentially be imaged by
PAT, whereas far fewer molecules are fluorescent. While both conventional ultrasound
imaging and PAT are based on ultrasonic detection, the former measures only mechanical
contrasts and the latter optical and thermoelastic contrasts.
PAT has been developed rapidly in the last decade, with applications explored in vascular
biology (8, 9), oncology (10, 11), neurology (12–14), ophthalmology (15, 16), dermatology
(17, 18), gastroenterology (19, 20), and cardiology (21, 22). Here, we first introduce the
fundamentals and three state-of-the-art embodiments of PAT. Next, the scalability of PAT
over four major length scales in biology—covering organelles, cells, tissues, and organs—is
highlighted. Then, rich photoacoustic contrasts are shown for tissue anatomies and
functions, as well as for metabolic, molecular, and genetic processes. To conclude, we
envision high-impact applications in biomedicine and point out remaining major challenges
in PAT.
Fundamentals and Major Implementations
PAT is based on optical excitation and ultrasonic detection. The biological tissue to be
imaged is irradiated usually by a nanosecond-pulsed laser beam to engender thermal and
acoustic impulse responses. The temporally confined optical absorption induces a
temperature rise ΔT and consequently an initial pressure rise p0 due to thermoelastic
expansion:p0 = β · ΔT/κ, where β and κ denote the thermal expansion coefficient and the
isothermal compressibility, respectively. Approximately, a 1-mK temperature rise results in
an 800-Pa pressure rise, which is above the noise level of a typical ultrasonic transducer. As
β and κ are beyond our control, it is fortunate that PAT can provide a high signal-to-noise
ratio without thermally damaging the tissue. After propagating through the tissue, the
pressure wave is detected by an ultrasonic transducer (or a set of transducers) to form a
high-resolution tomographic image of optical absorption. Although pulsed lasers are most
commonly used, intensity-modulated light sources may be used alternatively (23). Currently,
PAT has three major implementations: focused-scanning photoacoustic microscopy (PAM),
photoacoustic computed tomography (PACT), and photoacoustic endoscopy (PAE). While
PAM and PAE usually aim to image millimeters deep at micrometer-scale resolution, PACT
can be implemented for both microscopic and macroscopic imaging.
In PAM, both the optical excitation and ultrasonic detection are focused, and the dual foci
are usually configured confocally to maximize sensitivity. Each laser pulse produces a 1D
depth-resolved image without mechanical scanning, and 2D transverse scanning generates a
3D image. While the axial resolution is determined by the acoustic time of flight, the lateral
resolution is determined by the overlap of the dual foci. Quantitatively, the axial and lateral
resolutions are defined as the corresponding full widths at half maximum of the system
response to a point target. Depending on whether the optical or ultrasonic focus is finer,
PAM is further classified into optical-resolution (OR) (24, 25) and acoustic-resolution (AR)
PAM (26).
OR-PAM provides lateral resolution at the subcellular or cellular scale ranging from a few
hundred nanometers to a few micrometers (Fig. 1A). If such resolution were to be achieved
acoustically, the center frequency of the acoustic signal would have to be at least 300 MHz.
At such a high frequency, ultrasonic waves sustain severe propagation loss and can penetrate
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only a few hundred micrometers in tissue. Fortunately, optical focusing can readily confine
the photoacoustic excitation for high lateral resolution while maintaining substantial
imaging depth; in addition, acoustic focusing can improve detection sensitivity. This system
enables in vivo label-free functional imaging of hemoglobin oxygen saturation (sO2) in
vessels down to single capillaries (Fig. 1A). However, the imaging depth is limited by
optical diffusion to 1.2 mm in vivo (24).
In OR-PAM (Fig. 1A), the laser beam is focused by a microscope objective to a diffraction-
limited spot for excitation in the tissue. An optical-acoustic beam combiner, consisting of
two prisms sandwiching a thin layer of silicone oil, is positioned beneath the objective to
align the optical excitation and acoustic detection coaxially and confocally. The matched
optical refractive indices but mismatched acoustic impedances between the prism glass and
silicone oil provide optical transmission but acoustic reflection. The optical aberration
created by the optical transmission through the beam combiner is offset by a correction lens
attached to the top surface of the right-angle prism. To focus acoustic detection, a concave
acoustic lens is ground into the bottom of the rhomboid prism. An unfocused ultrasonic
transducer with a broad bandwidth matching that of the received acoustic waves is attached
to the top of the rhomboid prism. Although ideal for light transmission, the solid-liquid
interface adversely transforms 85% of the incident acoustic energy from longitudinal waves
to shear waves. Because shear waves are not detected with high sensitivity, the rhomboid
prism is used to regain the longitudinal wave at the second inclined surface.
At depths beyond the optical diffusion limit and up to a few millimeters, AR-PAM achieves
high resolution by taking advantage of the much lower acoustic scattering. Despite diffuse
optical excitation, lateral resolution of tens of micrometers is achieved by diffraction-limited
acoustic detection. In AR-PAM, optical excitation is implemented through dark-field
illumination, as shown in Fig. 1B, for two critical reasons. First, the donut-shaped
illumination eliminates otherwise dominant interference signals from the tissue surface.
Second, the donut hole is ideal for positioning the ultrasonic transducer coaxially and
confocally with respect to the optical excitation. The system provides a 45-μm lateral
resolution in vivo with a 3-mm imaging depth. Anatomical images of the human cutaneous
microvasculature in both the superficial epidermis and deep dermis have been acquired by
detecting hemoglobin (Fig. 1B) (18). However, to further advance the imaging depth to
centimeters for macroscopic imaging requires the use of more energetic lasers at low pulse
repetition rates. As a result, the transverse scanning becomes too slow for many clinical
applications.
To accelerate data acquisition, state-of-the-art ultrasonic array detectors have been utilized
for PACT. The entire region of interest (ROI) is excited by an expanded optical beam, and
the photoacoustic waves are simultaneously detected by an ultrasonic array. Then, an
inverse algorithm—essentially a method for sophisticated triangulation of photoacoustic
sources from the time-resolved acoustic signals—is used to reconstruct a high-resolution
image (27–30). As most ultrasonic arrays are 1D, the 2D resolutions in the imaging plane
are derived from reconstruction, whereas the orthogonal resolution comes from cylindrical
acoustic focusing. The imaging plane can be further translated along the orthogonal
dimension for 3D imaging. According to the anatomy of the organ of interest, the ultrasonic
array may be configured linearly (31) or circularly (32–34).
In linear-array PACT (Fig. 1C), a multimode optical fiber bundle is bifurcated to flank the
handheld ultrasonic array for dark-field optical illumination, as in AR-PAM. A single laser
pulse—with a safe exposure to the tissue (≤20 mJ/cm2 in the visible spectral range)—yields
a 2D image. A clinical ultrasound imaging system has been adapted for concurrent imaging
with PACT. This system, with a 400-μm axial resolution and a ~1 mm lateral resolution
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(35), has been used for noninvasive in vivo functional imaging of methylene-blue-labeled
sentinel lymph nodes in small animals (Fig. 1C) (10), and more recently in human breast
cancer patients (36).
Circular-array PACT (Fig. 1D) is designed to accommodate round objects, such as the brain,
a peripheral joint, and even the whole body of a small animal. The ROI is encircled by the
array to detect photoacoustic waves propagating along all in-plane directions; unlike the
partial-view detection (i.e., the angle subtended by the ultrasound detectors with respect to
the object is less than 360°) in linear-array PACT, full-view detection provides high-quality
images without missing boundaries (37). The principle of circular-array PACT was
originally demonstrated by circularly scanning a single-element ultrasonic transducer in the
first functional PAT system, which imaged the cerebral vascular response to one-sided
whisker stimulation in an adult rat through intact scalp and skull with an in-plane resolution
of ~200 μm (Fig. 1D) (14).
To image internal organs such as the esophagus and colon, PAE has been intensively
investigated in recent years (19–22, 38). In a representative PAE design (Fig. 1E) (19), light
from a high-repetition-rate laser is delivered by a multimode optical fiber placed in the
central hole of a ring transducer. An optically and acoustically reflective mirror, driven by a
micro-motor through coupled magnets, rotates both the optical illumination and the acoustic
detection for circumferential cross-sectional scanning. Further, a linear motor pulls back the
entire probe for volumetric imaging. While the imaging depth of conventional optical
endoscopy is within the optical diffusion limit, PAE has shown a 7-mm imaging depth in the
dorsal region of a rat colon ex vivo (Fig. 1E) (20).
Multiscale PAT in vivo: Organelles, Cells, Tissues, and Organs
The elegant marriage between light and sound endows PAT with the unique capability of
scaling its spatial resolution and imaging depth across both optical and ultrasonic
dimensions. The lateral resolution of OR-PAM is given by RL,OR = 0.51 · λ/NA, where λ
denotes the optical wavelength and NA the numerical aperture of the microscope objective.
Varying the NA can scale the lateral resolution—from as fine as sub-λ to a few λ’s—and the
imaging depth accordingly. With a 1.23 NA and a 532 nm wavelength, a 220-nm lateral
resolution has been achieved with an imaging depth of 100 μm, enabling in vivo subcellular
imaging of individual melanosomes (Fig. 2A) (39). Halving the NA to 0.63 quadruples the
imaging depth, while the lateral resolution is still maintained at submicrons, 500 nm (40).
Reducing the NA to 0.1 further triples the imaging depth to the optical diffusion limit and
relaxes the lateral resolution to 2.6 μm, enabling in vivo label-free functional imaging of
individual red blood cells flowing in capillaries (Fig. 2B) (24). As in conventional optical
microscopes, it is possible to combine multiple optical objectives of different NAs in a
single OR-PAM system, which would allow convenient adjustment of the magnification.
Further, OR- and AR-PAM systems can be integrated to extend the range of scalability of a
single device.
The lateral resolution of AR-PAM or partial-view PACT is given by RL,AR = 0.71 · vs/(NA ·
f0), where vs denotes the speed of sound, NA the acoustic numerical aperture, and f0 the
photoacoustic center frequency. The center frequency f0 is determined by the laser pulse
width, targeted tissue depth, and ultrasonic transducer’s frequency response. With a center
frequency of 50 MHz and an NA of 0.44, 45-μm lateral resolution and 3-mm imaging depth
have been achieved by AR-PAM (26). Such a system is adequate to see through human skin
lesions in vivo, as required for accurate diagnosis and staging (Fig. 2C) (18). Reducing the
center frequency to 5 MHz extends the imaging depth to 4 cm and relaxes the lateral
resolution to 560 μm (41). Because the resolution is now within the resolving power of
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human eyes, such an instrument is called a photoacoustic macroscope (PAMac). A PACT
system based on a clinical linear ultrasound array operating with a 4–8 MHz frequency band
has extended the imaging depth to 7 cm, with a sub-millimeter lateral resolution (720 μm)
(36). Figure 2D shows a representative in vivo PACT image of the breast vasculature in a
human volunteer (33). PACT can also perform microscopic imaging when operating at high
ultrasonic frequencies (42).
The axial resolution of PAM or partial-view PACT always originates from the time-of-
arrival of the acoustic signal. It can be estimated as RA = 0.88 · vs/δf, where Δf is the
photoacoustic bandwidth—approximately proportional to f0. So far, axial resolutions
ranging from 15 μm to 640 μm have been achieved in PAT systems of various targeted
imaging depths (25, 36). The 2D in-plane resolutions of full-view PACT can be similarly
estimated with Δf.
Figure 2E summarizes the scalability of PAT. Within the optical diffusion limit, the imaging
depth of OR-PAM is approximately proportional to the chosen lateral resolution. Beyond the
limit, the imaging depth is primarily determined by the frequency-dependent acoustic
attenuation. As both f0 and Δf are inversely proportional to the desired imaging depth, the
lateral and axial resolutions are proportional to the imaging depth. For both regimes, the
ratio of the imaging depth to the best spatial resolution is roughly a constant of 200, as
shown by the slope of the dashed line in Fig. 2E, making PAT a high-resolution modality
across all four length scales. The optimal tradeoff between spatial resolution and imaging
depth depends on the application.
Multi-contrast PAT in vivo: Anatomy, Function, Metabolism, and Molecular/
Genetic Processes
With selected optical wavelengths, PAT can probe a wide variety of endogenous or
exogenous absorbers to reveal the anatomy, function, metabolism, and molecular/genetic
processes in biological systems in vivo. Endogenously, DNA/RNA, hemoglobin, melanin,
water, and lipid are important anatomical and functional contrast agents. Using the strong
ultraviolet absorption of DNA and RNA, OR-PAM recently achieved noninvasive imaging
of individual cell nuclei (Fig. 3A), which can provide an in vivo label-free substitute for ex
vivo HE-staining histology (43). Because malfunction of DNA replication induces abnormal
nuclear morphology in cancer, this technology can potentially provide early detection and
intraoperative demarcation of cancer. Hemoglobin, as a primary oxygen carrier, is essential
to tissue metabolism. Using hemoglobin’s predominant optical absorption in the visible
range over other absorbers, PAT provides comprehensive anatomical and functional imaging
of the blood circulation system (8, 44). Abnormal concentrations of water and lipid can be
important disease indicators. Their relatively strong optical absorption in the near-infrared
range allows PAT to map their distributions at substantial depths in vivo (45, 46). Melanin, a
major pigment in the skin and most melanomas, has broadband optical absorption from the
ultraviolet to the near-infrared range, which can be spectroscopically distinguished from
hemoglobin absorption by PAT. Simultaneous imaging of the melanoma anatomy and the
surrounding vascular function provides an unprecedented opportunity for understanding the
interactions between tumor and its microenvironment and for noninvasively detecting and
staging melanoma (Fig. 3B) (26).
Exogenous contrast agents further extend PAT to molecular and genetic imaging.
Nanoparticles, organic dyes, and reporter gene products can be excellent photoacoustic
contrast agents. The primary advantage of gold nanoparticles lies in their large absorption
cross section tuned to the optical window (~730 nm), minimizing endogenous absorption
and maximizing imaging depth. Moreover, the bio-conjugation capability of nanoparticles
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enables effective biomarker targeting for both molecular imaging (Figs. 3C, D) (11, 47) and
drug delivery. Recently, the utilization of iron oxide and gold-coupled core-shell
nanoparticles as a photoacoustic contrast agent has led to the development of
magnetomotive PAT (Fig. 3E) (48), which markedly improves the contrast and specificity of
PAT by suppressing the non-magnetomotive background. Depending on the application, the
relatively slow tissue clearance of nanoparticles can be either an advantage or disadvantage.
While the clinical translation of most nanoparticles is still awaiting FDA approval, many
organic dyes have been approved for human use. Organic dyes clear rapidly from the body
because of their small molecular sizes (typically ~1 nm), and some can penetrate the blood-
brain barrier. Reporter gene products can be detected for PAT of biological processes at the
genetic level, as was demonstrated using the LacZ gene—a common reporter encoding the
protein β-galactosidase (49). Gliosarcoma cells transfected with LacZ genes were inoculated
into a Sprague-Dawley rat. As the tumor grew, LacZ genes expressed into β-galactosidase,
which metabolized the locally injected lactose-like substrate into highly absorbing blue
products, providing contrast for genetic PAT in vivo (Fig. 3F) (49). Even fluorescent
proteins from reporter genes have been imaged in vivo by PAT (Fig. 3G) (50).
All molecules can potentially be imaged by PAT at appropriate wavelengths, whereas only a
small subset of molecules is fluorescent. Even fluorophores can serve as absorbing contrast
agents for PAT (13, 50, 51). Optical excitation of fluorophores, in the absence of
photochemical relaxation, relaxes via either fluorescence or thermal emission. Because most
fluorophores have imperfect fluorescence quantum yields, PAT can rely on the thermal
relaxation for high-resolution deep imaging of fluorophores.
Besides the aforementioned static contrasts, PAT can also image two important dynamic
contrasts: blood flow (hemodynamic contrast) and temperature variation (thermodynamic
contrast). The recently discovered photoacoustic Doppler effect laid the foundation for PAT
of flow (52). Figure 3H shows a functional PAT image of both blood flow velocity and
direction in a living mouse (53). With excellent scalability, Doppler PAT bridges the spatial
gap between scattering-based optical and ultrasonic technologies. More importantly, the
high optical absorption contrast between the intravascular blood and extravascular
background greatly increases detection sensitivity.
Tissue temperature monitoring is essential for thermal therapy. Because the initial
photoacoustic pressure depends on the equilibrium temperature, PAT provides a potential
means for high-resolution temperature imaging deep in tissue (54, 55). Recent tissue
phantom experiments showed that the initial photoacoustic pressure increases with the
equilibrium temperature by ~5% per degree, which enables a sensitivity of the order of 0.1
degrees (54).
Combining both static and dynamic contrasts from PAT enables metabolic imaging. In fact,
PAT is the only modality that uses endogenous contrasts to measure all the parameters—
including the vessel diameter, total hemoglobin concentration, sO2, tissue volume of
interest, and blood flow velocity—required to compute the metabolic rate of oxygen
(MRO2). Recently, label-free absolute quantification of the MRO2 in a living mouse was
demonstrated (44).
Outlook
PAT is expected to find broad applications in biology and medicine. Major preclinical
applications include imaging of angiogenesis, microcirculation and tumor
microenvironments, drug response, brain functions, biomarkers, and gene activities. Initial
clinical applications include melanoma cancer imaging, gastrointestinal tract endoscopy,
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intravascular catheter imaging, neonatal brain imaging, breast cancer detection, prostate
cancer detection, guided sentinel lymph node needle biopsy for cancer staging, early
chemotherapeutic response imaging, dosimetry in thermal therapy, in vivo label-free
histology, blood perfusion imaging, blood oxygenation imaging, and tissue metabolism
imaging. While preclinical PAT systems have been commercialized, clinical systems need to
pass rigorous validation and arduous regulatory approval.
PAT is distinctly capable of in vivo metabolic imaging based on only endogenous contrast.
Upscaling metabolic PAT from small animals (44) to humans is expected to revolutionize
the screening, diagnosis, and treatment of metabolic diseases, particularly cancers and
cerebral disorders. Downscaling metabolic PAT to cells provides a tool for understanding
metabolic pathways. Because hypermetabolism is a quintessential hallmark of cancer,
metabolic PAT may enable in vivo cancer screening at the earliest stage without using
exogenous contrast agents.
The scalability of PAT provides an unprecedented opportunity to link a complex biological
system at multiple length scales through consistent optical absorption contrasts. In current
practice, microscopic biological structures including organelles and cells are usually imaged
using optical microscopy, while macroscopic structures including tissues and organs are
imaged using non-optical modalities such as X-ray computed tomography. Their vastly
different contrast mechanisms make correlating microscopic and macroscopic images
challenging. Imaging the same contrast enables PAT to bridge this gap between the
microscopic and macroscopic domains. Therefore, experimental observations from
multiscale PAT are expected to facilitate the development of theoretical models for systems
biology that explain and even predict biological phenomena at multiple scales. Moreover,
PAT will most likely accelerate the translation of microscopic laboratory discoveries to
macroscopic clinical practice.
PAT still need to meet multiple technical challenges to maximize its impact in biomedicine.
For high-speed multi-contrast PAM or PAE based on spectroscopy, high-repetition lasers
with fast wavelength-tuning at each scan position must be developed. PAE probes require
further miniaturization to fit within generic endoscopes or even intravascular catheters. For
deep-penetrating PACT, high-energy lasers with video-rate pulse repetition are needed. The
required laser energy, however, can potentially be lowered by using time-reversed
ultrasonically encoded (TRUE) optical focusing to improve light penetration (56). Also
needed are sophisticated algorithms to perfect molecular quantification and to suppress
skull-induced artifacts. It is highly anticipated that further advancement of this fast-growing
imaging technology will revolutionize both fundamental life sciences and clinical patient
care.
Acknowledgments
The authors appreciate Prof. James Ballard’s close reading of the manuscript. Thanks to Junjie Yao for providing
Fig. 3H. This work was sponsored by National Institutes of Health Grants R01 EB000712, R01 EB008085, R01
CA134539, U54 CA136398, R01 CA157277, R01 EB010049, and R01 CA159959. L.V.W. has financial interests
in Microphotoacoustics, Inc. and Endra, Inc., which, however, did not support this work.
References and Notes
1. Wang, LV.; Wu, H. Biomedical Optics: Principles and Imaging. Wiley; Hoboken, NJ: 2007.
2. The optical diffusion limit represents the depth of the quasi-ballistic regime in biological tissue
beyond which light propagating along the predefined linear trajectory becomes too weak to be
detected in practice. It is usually equated with the transport mean free path, i.e., the mean distance
between two consecutive equivalent isotropic scattering events.
Wang and Hu Page 7













3. Culver JP, Ntziachristos V, Holboke MJ, Yodh AG. Opt Lett. 2001; 26:701. [PubMed: 18040425]
4. Wang LV. Nat Photon. 2009; 3:503.
5. The sensitivity is defined here as the ratio of the fractional change in the photoacoustic signal to the
fractional change in the optical absorption coefficient.
6. Wang LV. IEEE J Sel Top Quantum Electron. 2008; 14:171.
7. Guo Z, Li L, Wang LV. Med Phys. 2009; 36:4084. [PubMed: 19810480]
8. Oladipupo S, et al. Proc Natl Acad Sci USA. 2011; 108:13264. [PubMed: 21784979]
9. Oladipupo SS, et al. Blood. 2011; 117:4142. [PubMed: 21307392]
10. Erpelding TN, et al. Radiology. 2010; 256:102. [PubMed: 20574088]
11. Kim C, et al. ACS Nano. 2010; 4:4559. [PubMed: 20731439]
12. Hu S, Wang LV. Front Neuroenerg. 2010; 210.3389/fnene.2010.00010
13. Hu S, Yan P, Maslov K, Lee JM, Wang LV. Opt Lett. 2009; 34:3899. [PubMed: 20016651]
14. Wang X, et al. Nat Biotechnol. 2003; 21:803. [PubMed: 12808463]
15. Hu S, Rao B, Maslov K, Wang LV. Opt Lett. 2010; 35:1. [PubMed: 20664653]
16. Jiao S, et al. Opt Express. 2010; 18:3967. [PubMed: 20389409]
17. Zhang EZ, et al. Biomed Opt Express. 2011; 2:2202. [PubMed: 21833358]
18. Favazza CP, Jassim O, Cornelius LA, Wang LV. J Biomed Opt. 2011; 16:016015. [PubMed:
21280921]
19. Yang JM, et al. Opt Lett. 2009; 34:1591. [PubMed: 19448831]
20. Yang JM, et al. Proc SPIE. 2012; 8223
21. Jansen K, van der Steen AFW, van Beusekom HMM, Oosterhuis JW, van Soest G. Opt Lett. 2011;
36:597. [PubMed: 21368919]
22. Wang B, et al. Nano Lett. 2008; 9:2212. [PubMed: 18844426]
23. Maslov K, Wang LV. J Biomed Opt. 2008; 13:024006. [PubMed: 18465969]
24. Hu S, Maslov K, Wang LV. Opt Lett. 2011; 36:1134. [PubMed: 21479007]
25. Maslov K, Zhang HF, Hu S, Wang LV. Opt Lett. 2008; 33:929. [PubMed: 18451942]
26. Zhang HF, Maslov K, Stoica G, Wang LV. Nat Biotechnol. 2006; 24:848. [PubMed: 16823374]
27. Kostli KP, et al. IEEE J Sel Top Quantum Electron. 2001; 7:918.
28. Xu M, Wang LV. IEEE Trans Med Imaging. 2002; 21:814. [PubMed: 12374318]
29. Finch D, Patch SK, Rakesh SIAM. J Math Anal. 2003; 35:1213.
30. Xu M, Wang LV. Phys Rev E. 2005; 71:016706.
31. Zemp RJ, et al. J Biomed Opt. 2007; 12:010501. [PubMed: 17343475]
32. Brecht HP, et al. J Biomed Opt. 2009; 14:064007. [PubMed: 20059245]
33. Kruger RA, Lam RB, Reinecke DR, Del Rio SP, Doyle RP. Med Phys. 2010; 37:6096. [PubMed:
21158321]
34. Li C, et al. J Biomed Opt. 2010; 15:010509. [PubMed: 20210422]
35. Kim C, Erpelding TN, Jankovic L, Pashley MD, Wang LV. Biomed Opt Express. 2010; 1:278.
[PubMed: 21258465]
36. Wang, LV. Isaac Newton Institute for Mathematical Sciences: Inverse Problems. Cambridge, U.K:
2011.
37. Xu Y, Wang LV, Ambartsoumian G, Kuchment P. Med Phys. 2004; 31:724. [PubMed: 15124989]
38. Yang Y, et al. Biomed Opt Express. 2011; 2:2551. [PubMed: 21991547]
39. Zhang C, Maslov K, Wang LV. Opt Lett. 2010; 35:3195. [PubMed: 20890331]
40. Zhang C, et al. J Biomed Opt. in press.
41. Song KH, Wang LV. J Biomed Opt. 2007; 12:060503. [PubMed: 18163798]
42. Song L, Maslov K, Wang LV. Opt Lett. 2011; 36:1236. [PubMed: 21479041]
43. Yao D, Maslov K, Shung KK, Zhou Q, Wang LV. Opt Lett. 2010; 35:4139. [PubMed: 21165116]
44. Yao J, Maslov KI, Zhang Y, Xia Y, Wang LV. J Biomed Opt. 2011; 16:076003. [PubMed:
21806264]
45. Xu Z, Zhu Q, Wang LV. J Biomed Opt. 2011; 16:066020. [PubMed: 21721821]
Wang and Hu Page 8













46. Wang HW, et al. Phys Rev Lett. 2011; 106:238106. [PubMed: 21770549]
47. De la Zerda A, et al. Nat Nanotechnol. 2008; 3:557. [PubMed: 18772918]
48. Jin Y, Jia C, Huang SW, O’Donnell M, Gao X. Nat Commun. 2010; 1:41. [PubMed: 20975706]
49. Li L, Zhang HF, Zemp RJ, Maslov K, Wang LV. J Innov Opt Health Sci. 2008; 1:207. [PubMed:
19946613]
50. Razansky D, et al. Nat Photon. 2009; 3:412.
51. Razansky D, Vinegoni C, Ntziachristos V. Opt Lett. 2007; 32:2891. [PubMed: 17909608]
52. Fang H, Maslov K, Wang LV. Phys Rev Lett. 2007; 99:184501. [PubMed: 17995411]
53. Yao J, Maslov K, Shi Y, Taber LA, Wang LV. Opt Lett. 2010; 35:1419. [PubMed: 20436589]
54. Pramanik M, Wang LV. J Biomed Opt. 2009; 14:054024. [PubMed: 19895126]
55. Shah J, et al. J Biomed Opt. 2008; 13:034024. [PubMed: 18601569]
56. Xu X, Liu H, Wang LV. Nat Photon. 2011; 5:154.
Wang and Hu Page 9














Major embodiments of PAT, with representative in vivo images. (A) OR-PAM of sO2 in a
mouse ear. (B) AR-PAM of normalized total hemoglobin concentration, [Hemoglobin], in a
human palm. (C) Linear-array PACT of normalized methylene blue concentration, [Dye], in
a rat sentinel lymph node (SLN). (D) Circular-array PACT of cerebral hemodynamic
changes, Δ[Hemoglobin], in response to one-sided whisker stimulation in a rat. (E) PAE of a
rabbit esophagus and adjacent internal organs, including the trachea and lung. UST:
ultrasonic transducer.
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Multiscale PAT of organelles, cells, tissues, and organs in vivo. (A) Sub-wavelength (SW)
PAM of melanosomes in the ear of a black mouse. (B) OR-PAM of individual red blood
cells traveling along a capillary in a mouse ear. (C) AR-PAM of a nevus on a human
forearm. (D) PACT of a human breast. (E) Imaging depth versus spatial resolution in PAT.
SM, sub-micron; LA, linear-array.
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Multi-contrast PAT of tissue anatomy, function, molecular biomarkers, and gene expression.
(A) OR-PAM of epithelial cell nuclei in the intestinal villi of a mouse ex vivo by excitation
of DNA and RNA. (B) AR-PAM of a subcutaneously inoculated B16-melanoma and the
surrounding vasculature on the back of a living mouse. (C) AR-PAM of a subcutaneously
inoculated B16-melanoma labeled with targeted gold nanocages on the back of a living
mouse. (D) Dual-contrast ultrasound (gray) and photoacoustic (green) imaging of a single-
walled carbon nanotube targeted tumor in a living mouse. (E) Magnetomotive PAT of a
polyvinyl alcohol phantom with three 2-mm-diameter inclusions. The left inclusion contains
gold nanorods with absorption comparable to the 3 nM magnetic-gold hybrid nanoparticles
placed in the center inclusion, and the right inclusion contains 3 nM magnetic nanoparticles.
(F) AR-PAM of a lacZ-marked 9L gliosarcoma and the surrounding vasculature under the
scalp of a living rat. (G) PACT of the brain of a six-month-old mCherry-expressing
transgenic zebrafish. (H) OR-PAM of blood flow velocity and direction in the ear of a living
mouse.
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